CHMP2B and amyotrophic lateral sclerosis: Mutations in the gene encoding the ESCRT-III component charged multivesicular body protein 2B (CHMP2B) are associated with frontotemporal dementia (FTD), FTD with motor neuron disease, and amyotrophic lateral sclerosis (ALS) [70,71,72].